Literature DB >> 29447100

Extending Oncology Clinical Services to Rural Areas of Texas Via Teleoncology.

Jivesh J Sharma1, Gary Gross1, Poonam Sharma1.   

Abstract

Abstracts Purpose: For patients in rural Texas, accessing cancer specialists is quite challenging. Texas has many remote areas without community-based cancer care, requiring patients to travel long distances for specialized cancer professional consultations and services. An anticipated shortage of medical oncology expertise will exacerbate this situation. The advent of telemedicine tools has created an opportunity to easily extend specialized cancer services to underserved populations of patients with cancer in Texas. However, more research is needed to explore how well telemedicine tools will be accepted and used by both patients and oncologists alike. Data suggesting that teleoncology services are well accepted and liked by patients and health care professionals would provide a basis for expanding this method of delivering care. If effective, telemedicine tools could help patients with cancer in rural Texas, and throughout the United States, access the same quality of cancer care as their counterparts living in urban areas.
METHODS: This pilot study will compare the effectiveness and reliability of remote oncologic clinical evaluations conducted via a telemedicine application with the traditional method of onsite evaluations in a private practice setting in rural East Texas. Patient and physician satisfaction with the clinical consultations and their perceptions of the telemedicine application will be assessed using a questionnaire administered at the conclusion of the clinical meetings.
RESULTS: Initial results indicate high patient and physician satisfaction scores as well as high reliability and adequacy of the equipment and technology being used.
CONCLUSION: Both patients and physicians are highly satisfied with the quality of teleoncology examinations and express openness to this method of delivering care.

Entities:  

Year:  2012        PMID: 29447100      PMCID: PMC3457822          DOI: 10.1200/JOP.2011.000436

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  6 in total

1.  Breast Medical Oncologists' Perspectives of Telemedicine for Breast Cancer Care: A Survey Study.

Authors:  Eleni Stavrou; Jeanna Qiu; Affan Zafar; Angela C Tramontano; Steven Isakoff; Eric Winer; Deborah Schrag; Christopher Manz
Journal:  JCO Oncol Pract       Date:  2022-06-07

2.  Access to telehealth services for colorectal cancer patients in the United States during the COVID-19 pandemic.

Authors:  Victoria A Marks; Walter R Hsiang; Waez Umer; Afash Haleem; Dana Kim; John W Kunstman; Michael S Leapman; Kevin M Schuster
Journal:  Am J Surg       Date:  2022-06-08       Impact factor: 3.125

3.  Virtual visits among gynecologic oncology patients during the COVID-19 pandemic are accessible across the social vulnerability spectrum.

Authors:  Lindsey A McAlarnen; Shirng-Wern Tsaih; Rana Aliani; Natasha M Simske; Elizabeth E Hopp
Journal:  Gynecol Oncol       Date:  2021-05-11       Impact factor: 5.304

4.  Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations.

Authors:  Majed Alshamrani; Atika AlHarbi; Nora Alkhudair; Fouad AlNajjar; Mansoor Khan; Abdulaziz Ben Obaid; Amr Khardaly; Eshtyag Bajnaid; Hadeel Samarkandi; Aeshah AlAzmi; Salman Alabdali; Mohammed AlNahedh
Journal:  J Oncol Pharm Pract       Date:  2020-06-24       Impact factor: 1.809

5.  Agreement between face-to-face and tele-assessment of upper limb disability in lung cancer survivors during COVID-19 era.

Authors:  Alejandro Heredia-Ciuró; Antonio Lazo-Prados; Paula Blasco-Valls; Andrés Calvache-Mateo; Laura Lopez-Lopez; Javier Martin-Nuñez; Marie C Valenza
Journal:  J Telemed Telecare       Date:  2022-02-25       Impact factor: 6.184

6.  Mobile Health App for Prostate Cancer Patients on Androgen Deprivation Therapy: Qualitative Usability Study.

Authors:  Junaid Nabi; Eugene B Cone; Anjali Vasavada; Maxine Sun; Kerry L Kilbridge; Adam S Kibel; Donna L Berry; Quoc-Dien Trinh
Journal:  JMIR Mhealth Uhealth       Date:  2020-11-03       Impact factor: 4.773

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.